AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma

DISEASE CHARACTERISTICS: * Histologically or cytologically confirmed diagnosis of 1 of the following: * Advanced and/or metastatic solid tumor * No more than 3 prior regimens for metastatic disease * Refractory non-Hodgkin's lymphoma * Clinically or radiologically documented disease * Patients whose only evidence of disease is tumor marker elevation are not eligible * No untreated brain or meningeal metastases * Patients with radiologic or clinical evidence of stable, treated brain metastases are eligible provided they are asymptomatic AND have no requirement for corticosteroids PATIENT CHARACTERISTICS: * ECOG performance status 0-2 * Absolute granulocyte count ≥ 1,500/mm³ * Platelet count ≥ 100,000/mm³ * Creatinine ≤ 1.25 times upper limit of normal (ULN) OR creatinine clearance ≥ 50 mL/min * Bilirubin normal * ALT and AST ≤ 2 times ULN (5 times ULN if patient has documented liver metastases) * Potassium normal * Calcium normal * Creatine kinase (CK or CPK) ≤ 2 times ULN * Not pregnant or nursing * Negative pregnancy test * Fertile patients must use effective contraception * No pre-existing cardiovascular conditions and/or symptomatic cardiac dysfunction, including any of the following: * Significant cardiac event (including symptomatic heart failure or angina) within the past 3 months or any cardiac disease that, in the opinion of the investigator, increases the risk for ventricular arrhythmia * Any history of ventricular arrhythmia, which was sympto…